FMR CORP 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 10,404,096 14.040% |
-218,767 (-2.06%) |
Filing |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 10,622,863 14.999% |
5,697,486 (+115.68%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 4,925,377 7.412% |
1,148,853 (+30.42%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 3,776,524 8.052% |
352,389 (+10.29%) |
Filing |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 3,424,135 9.124% |
591,283 (+20.87%) |
Filing |
| 2020-07-10 11:38 am Purchase |
2020-07-09 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 2,832,852 7.552% |
909,887 (+47.32%) |
Filing |
| 2020-06-19 10:30 am Purchase |
2020-06-19 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 1,922,965 5.439% |
1,922,965 (New Position) |
Filing |